Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You are reasonably active and able to care for yourself, with little or no limitation in daily activities (this is measured on a scale used by doctors called ECOG, scored 0–2)
- You have been diagnosed with a specific type of cervical cancer (either squamous cell carcinoma or adenocarcinoma) confirmed by a tissue sample
- Your cervical cancer has been classified at a certain stage of severity (FIGO stage IB2 to IVA, based on 2018 guidelines — confirm with trial site if unsure what stage you are)
- You are able to have an MRI scan of your pelvis (no medical reasons preventing this)
- You are willing to give written agreement to take part in the study (informed consent)
Who may not be able to join:
- You are under 18 years of age
- Your general health and ability to carry out daily activities is significantly limited (ECOG score above 2)
- You have had another type of cancer within the last 10 years
- You have previously had radiation therapy to the area of the body being treated in this trial
- You have certain health conditions that make radiation treatment unsafe, such as specific genetic conditions causing extreme sensitivity to radiation, ulcerative colitis, a flare-up of diverticulitis, severe diverticulosis, or long-term pelvic inflammation
- You have serious internal health problems that would make chemotherapy or combined chemotherapy and radiation treatment unsafe, such as severe liver disease, serious heart conditions, or kidney failure
- Your cancer has spread to parts of the body other than the lymph nodes in the pelvis
- You have any other significant health condition that, in the doctor's opinion, could affect your ability to fully take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: VALENTINA LANCELLOTTA, Fondazione Universiataria Policlinico A Gemelli IRCCS
Phone: 3441177911
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acute and late gastrointestinal toxicity; Acute and late urinary toxicity; Sexual activity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.